We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
199 hedge funds and large institutions have $2.93B invested in Denali Therapeutics in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 53 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
616% more call options, than puts
Call options by funds: $1.93M | Put options by funds: $270K
62% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 53
3.03% more ownership
Funds ownership: 74.95% → 77.97% (+3%)
3% more capital invested
Capital invested by funds: $2.84B → $2.93B (+$92.6M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 200 → 199 (-1)
4% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 28
Holders
199
Holders Change
-1
Holders Change %
-0.5%
% of All Funds
3.2%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
86
Reduced
53
Closed
28
Calls
$1.93M
Puts
$270K
Net Calls
+$1.66M
Net Calls Change
-$883K
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.9M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$13.6M |
| 3 |
CM
Crestline Management
Fort Worth,
Texas
|
-$8.93M |
| 4 |
Morgan Stanley
New York
|
-$7.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.1M |
